TECNIS Intraocular Lenses for Presbyopia
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of the study is to evaluate the binocular clinical endpoints of distance, intermediate, and near vision and patient reported outcomes utilizing mini-monovision versus mix-match approaches for the correction of presbyopia with intraocular lenses.
Who Is on the Research Team?
Daniel H Chang, MD
Principal Investigator
Empire Eye and Laser Center
Are You a Good Fit for This Trial?
This trial is for adults who need cataract surgery and want to correct presbyopia (age-related trouble seeing up close). Participants should be healthy enough for eye surgery and not have other serious eye diseases or conditions that could affect vision results.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Trial Overview
The study compares two ways of using artificial lenses during cataract surgery: one uses the same TECNIS PureSee lens in both eyes with a slight difference in focus (mini-monovision), while the other uses a mix of TECNIS PureSee and TECNIS Odyssey lenses. The goal is to see which method gives better overall vision without glasses.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Participants will receive a TECNIS PureSee IOL (Model DEN00V/DET150) in their dominant eye and a TECNIS Odyssey IOL (Model DRN00V/DRT150) in their non-dominant eye.
Participants will receive bilateral TECNIS PureSee IOLs (Model DEN00V/DET150), with the non-dominant eye targeted for a "second minus" near aim to achieve mini-monovision.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dr. Daniel H. Chang, MD
Lead Sponsor
Johnson & Johnson Surgical Vision, Inc.
Industry Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.